Development of a novel hypoxia-immune–related lncrna risk signature for predicting the prognosis and immunotherapy response of colorectal cancer
HIGHLIGHTS who: Likun Luan and colleagues from the University of Texas MD Anderson Cancer Center, United States have published the […]